Top Midday Gainers
Kymera Therapeutics (KYMR) has completed enrollment in its phase 2b Broaden2 trial of KT-621 in moderate-to-severe atopic dermatitis ahead of schedule, the company said Thursday.Shares jumped 17% following an increase in intraday trading volume to about 2.7 million from a daily average of about 636,000.WidePoint (WYY) stock surged 14% after the company said it won the Department of Homeland Security's Cellular Wireless Managed Services 3.0 contract.More than 5.4 million shares of the company traded intraday compared with a daily average of about 140,000.Bio-Techne (TECH) signed a definitive agreement to be acquired by Merck KGaA for $73 a share, representing an enterprise value of $11.3 billion, the companies said Thursday.Shares climbed 20% as intraday trading volume catapulted to over 40.7 million from a daily average of about 2.7 million.Price: $116.86, Change: $+16.99, Percent Change: +17.01%
